 Optimization of the late consolidation therapy in standard risk patients SR by a prospective randomized trial comparing a high-dose cytarabinedaunorubicin HD-Ara-CDNR based late consolidation therapy with an autologous peripheral blood stem cell transplantation PBSCT 